Literature DB >> 19585675

IgE myeloma with elevated level of serum CA125.

Man-Ling Wang1, Qiang Huang, Tian-Xin Yang.   

Abstract

OBJECTIVE: To explore clinical and laboratory features and significance of detecting serum carbohydrate antigen 125 (CA125) in immunoglobulin E (IgE) multiple myeloma.
METHODS: We reported the clinical findings of a male patient with IgE myeloma and elevated level of serum CA125 and reviewed the literature.
RESULTS: Laboratory tests of this patient on admission showed extremely high serum IgE and CA125, a bone marrow aspirate revealed abnormal plasma cells (38.4% of nucleated cells: 16.4% mature and 22% atypical), and in bone marrow biopsy, immunoperoxidase staining showed positive cytoplasmic staining for IgE and kappa light chain within the vast majority of plasma cells. Computed tomography (CT) bone scans indicated wedge shape change and compressive fracture of thoracic vertebrae, and emission computed tomography (ECT) discovered multiple punctiform aggregation of radiation in both cervical ribs and spine. The serum IgE and CA125 gradually decreased to normal limits after eight cycles of chemotherapy. This patient is alive well with an 18-month complete remission.
CONCLUSION: We reported the first case of IgE myeloma with elevated level of serum CA125. To further evaluate clinical characteristics and significance of CA125 in IgE myeloma, more cases are needed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19585675      PMCID: PMC2704975          DOI: 10.1631/jzus.B0820399

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  18 in total

1.  [IgE multiple myeloma. A case report and review of the literature].

Authors:  T Koh; T Ohno; S Kageyama; N Shimizu; T Uchida; I Tanaka; T Kobayashi; Y Karitani; S Shirakawa
Journal:  Nihon Ketsueki Gakkai Zasshi       Date:  1986-05

Review 2.  IgE myeloma: a case presentation and a review of the literature.

Authors:  K J Kairemo; M Lindberg; M Prytz
Journal:  Scand J Clin Lab Invest       Date:  1999-10       Impact factor: 1.713

Review 3.  IgE lambda monoclonal gammopathy and amyloidosis.

Authors:  J M Jako; T Gesztesi; I Kaszas
Journal:  Int Arch Allergy Immunol       Date:  1997-04       Impact factor: 2.749

4.  [A case of IgE myeloma (author's transl)].

Authors:  J Kimura; N Suzuki; H Tomioka; H Takahashi
Journal:  Rinsho Ketsueki       Date:  1981-09

5.  Tumor Markers in Ovarian Malignancies.

Authors: 
Journal:  Oncologist       Date:  1997

6.  Monoclonal IgE with renal failure.

Authors:  A O Vladutiu; R K Kohli; A P Prezyna
Journal:  Am J Med       Date:  1976-12       Impact factor: 4.965

7.  Long-term follow-up study on the role of serum CA-125 as a prognostic factor in 221 newly diagnosed patients with Hodgkin's lymphoma.

Authors:  Filippo Russo; Secondo Lastoria; Gino Svanera; Gaetana Capobianco; Anna de Chiara; Raffaele di Francia; Elisabetta Squame; Franco de Martinis; Antonio Pinto
Journal:  Leuk Lymphoma       Date:  2007-04

8.  A new case of IgE myeloma.

Authors:  R L Alexander; S T Roodman; P J Petruska; C C Tsai; C G Janney
Journal:  Clin Chem       Date:  1992-11       Impact factor: 8.327

9.  "Benign" monoclonal IgE gammopathy.

Authors:  H Ludwig; W Vormittag
Journal:  Br Med J       Date:  1980-08-23

10.  T-cell subpopulations in patients with monoclonal gammopathies: essential monoclonal gammopathy, multiple myeloma, and Waldenstrom macroglobulinemia.

Authors:  J F San Miguel; M D Caballero; M Gonzalez
Journal:  Am J Hematol       Date:  1985-11       Impact factor: 10.047

View more
  3 in total

1.  Bortezomib plus melphalan and prednisone (VMP regimen) as the initial treatment for IgE multiple myeloma: a case study.

Authors:  Hiroyuki Sato; Yusuke Komiya; Shigeru Hoshino
Journal:  Int J Hematol       Date:  2014-03-28       Impact factor: 2.490

2.  Prozone effect of serum IgE levels in a case of plasma cell leukemia.

Authors:  Giampaolo Talamo; William Castellani; Nathan G Dolloff
Journal:  J Hematol Oncol       Date:  2010-09-10       Impact factor: 17.388

3.  Non-secretory immunoglobulin E myeloma associated with immunoglobulin G monoclonal gammopathy of undetermined significance.

Authors:  Masako Yasuyama; Toshie Ogasawara; Kuniaki Otsuka; Motohiko Aiba; Kiyotaka Kawauchi
Journal:  Hematol Rep       Date:  2012-07-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.